Marshall Wace’s Genetron Holdings Limited ADS GTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-68,976
Closed -$351K 3937
2022
Q2
$351K Sell
68,976
-52,544
-43% -$270K ﹤0.01% 2962
2022
Q1
$798K Buy
121,520
+114,233
+1,568% +$1.25M ﹤0.01% 2547
2021
Q4
$133K Buy
+7,287
New +$242K ﹤0.01% 3304
2021
Q3
Sell
-5,060
Closed -$306K 3551
2021
Q2
$306K Sell
5,060
-62,926
-93% -$3.88M ﹤0.01% 2316
2021
Q1
$4.38M Buy
67,986
+29,675
+77% +$2.04M 0.02% 911
2020
Q4
$1.61M Buy
+38,311
New +$1.39M 0.01% 1035

Other funds holding GTH

Marshall Wace's GTH Position: Q3 2022 in Review

Marshall Wace sold out of Genetron Holdings Limited ADS (GTH) in Q3 2022, closing a stake of 68,976 shares — an estimated $351K sold.

Marshall Wace first reported a position in GTH in Q4 2020 and held it in 6 quarters. The position peaked at $4.38M in Q1 2021. 25 funds tracked by Wall St. Rank hold GTH as of Q3 2022.

  • Marshall Wace reported no remaining Genetron Holdings Limited ADS position as of Q3 2022 after selling out during the quarter.
  • Marshall Wace sold 68,976 Genetron Holdings Limited ADS shares in Q3 2022, an estimated $351K.
  • Marshall Wace first reported a position in Genetron Holdings Limited ADS in Q4 2020 and held it in 6 quarters.
  • Marshall Wace's Genetron Holdings Limited ADS position peaked at $4.38M in Q1 2021.
  • 25 funds tracked by Wall St. Rank held Genetron Holdings Limited ADS as of Q3 2022.

Based on Marshall Wace's 13F filing for Q3 2022, filed 14 Nov 2022.